The Tata Motors Group on Tuesday reported a 2 per cent year-on-year growth in global wholesales, including Jaguar land Rover (JLR), at 3,34,884 units in the March quarter of FY22.
From govt fast-tracking approval for foreign-produced Covid vaccines to JLR reporting over 12% rise in Q4 retail sales, here are top headlines this evening.
The company refuses to give a launch timeline, says it is in talks with battery makers and suppliers to localise a large portion of manufacturing in order to bring the cost down
At the bourses, shares of Tata Motors surged 32.3 per cent during the September quarter as compared to 9 per cent gain in the S&P BSE Sensex, ACE Equity data show
The company's sales, however, improved by 50 per cent during the July-September quarter as against 74,067 units in April-June period of the current fiscal
Tata has begun to address some of the financial issues facing JLR, providing the brand with a $910 million equity infusion to help bolster its balance sheet.
The company said these critical steps will also support and grow the existing supply chain, making the UK less dependent on essential materials sourced abroad today
JLR India president and managing director Rohit Suri is bullish about a spike in volumes despite the end of the lower taxation boost that GST regime offered